Navigation Links
Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
Date:8/29/2013

imes, as well as planned interaction with research analysts and institutional investors)
  • Corporate Governance information
  • About Eli Lilly and Company
    Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers — through medicines and information — for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

    C-LLY

    FOR MORE INFORMATION, CONTACT:

    Alex Kepnes
    Humana Corporate Communications 
    502-580-2990
    akepnes@humana.com  

    Kelley Murphy
    Eli Lilly and Company
    317-701-4007
    murphy_kelley@lilly.com   

    (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

    (Logo: http://photos.prnewswire.com/prnh/20130829/DE70165LOGO )


    '/>"/>
    SOURCE Eli Lilly and Company; Humana Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Comprehensive Care Corporation Announces New Medicare Contract with Humana Health Plan of California, Inc.
    2. Dr. Marschall S. Runge Elected to Lilly Board of Directors
    3. Lilly Reports Second-Quarter 2013 Results
    4. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    5. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
    6. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
    7. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
    8. Lilly Declares Third-Quarter 2013 Dividend
    9. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
    10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
    11. Lilly Statement on Indiana Biosciences Research Institute
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/6/2015)... 6, 2015  The German Court of Appeal has ruled ... vitamin regimen patent for Alimta® (pemetrexed disodium) would not be ... dipotassium salt form of pemetrexed in Germany ... The German Court ruled in favor of the ... v. Actavis. This decision vacated the prior decision of the ...
    (Date:3/6/2015)... 6 de marzo de 2015 TeraRecon, ... gestión empresarial de imagen médica, fortalece su posición ... de Randolph Sternberg como director de ... director de operaciones. Logo - ... será responsable de las ventas y desarrollo empresarial ...
    (Date:3/6/2015)... , March 6, 2015 ... des cohortes de patients pouvant bénéficier de l,innovation ... des solutions d,enrichissement sémantique de contenu pour l,Entreprise, ... par UNICANCER, Groupe des Centres de lutte contre ... cadre de son projet ConSoRe (Continuum Soin-Recherche) conduit ...
    Breaking Medicine Technology:German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4
    ... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
    ... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
    Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
    (Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Center. After being away from the touring business for ... of letting up on his “Garth Brooks World Tour.” The ... Yearwood, to venues around the United States. The duo recently ... to the Moda Center in Portland, OR. The husband and ...
    (Date:3/6/2015)... As the Muscular Dystrophy Association continues ... organization has hired two new Scientific Program Officers, Amanda ... report to Grace Pavlath, Ph.D, who joined MDA late ... Director, and together will lead MDA as it accelerates ... for various types of neuromuscular and motor neuron diseases. ...
    (Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
    (Date:3/6/2015)... Johnson & Johnson and Ethicon were hit ... 2015 in Superior Court in the State of California ... of 12 awarded Mrs. Perry $700,000 in actual damages ... Ethicon TVT Abbrevo plastic sling for stress urinary incontinence. ... awarded $5 million in punitive damages. , According to ...
    (Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
    Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
    ... could bring new treatment options for patients, researchers ... Surgery patients may one day find nicotine patches ... pad, researchers say. , Nicotine patches and the ... surgery, according to two studies presented at the ...
    ... Texas, 181,legislators are being honored with the Texas ... on behalf of health care,during the 80th Session ... the award in 1997 to honor state legislators ... issues important,to hospitals and health systems. Recipients ...
    ... Arthur H. Rubenstein,MBBCh, executive vice president for the health ... Dunlop professor of medicine at the University,of Pennsylvania, has ... the,Association of Academic Health Centers., Dr. Rubenstein served ... New,York before assuming his current position at the University ...
    ... stomach risks, study notes , , MONDAY, Oct. 15 ... their doctors that they take common over-the-counter painkillers, such ... new study has found. , "With nearly one out ... no wonder that adverse events are increasing yearly," said ...
    ... 15 /PRNewswire/ - Neuromed,Pharmaceuticals, a biopharmaceutical company developing ... has successfully reached an,agreement with the U.S. Food ... (SPA) process for the planned pivotal Phase 3,clinical ... of,chronic pain. A SPA is a procedure by ...
    ... Edwards Lifesciences,Corporation (NYSE: EW ), a global ... plans to announce its operating,results for the quarter ended ... 22, 2007 and will host a conference call at ... To participate in the conference call, dial (877) 407-8037 ...
    Cached Medicine News:Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 2Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 3Health News:THA Honors Nine Legislators for Contributions to Health Care 2Health News:Association of Academic Health Centers Names University of Pennsylvania's Dr. Arthur H. Rubenstein Chairman of the Board of Directors 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 2Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 3Health News:Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007 2
    Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
    Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours....
    ... Portex® Thermovent® T helps provide protection to the ... small and extremely lightweight making it ideal for ... a high rate of heat and moisture recovery, ... ,All HMEs and filters have ISO standard ...
    This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
    Medicine Products: